NO853241L - Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse - Google Patents

Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse

Info

Publication number
NO853241L
NO853241L NO853241A NO853241A NO853241L NO 853241 L NO853241 L NO 853241L NO 853241 A NO853241 A NO 853241A NO 853241 A NO853241 A NO 853241A NO 853241 L NO853241 L NO 853241L
Authority
NO
Norway
Prior art keywords
cells
compounds
hydrogen
cell
cdm
Prior art date
Application number
NO853241A
Other languages
English (en)
Norwegian (no)
Inventor
Adam Kovacs
Original Assignee
Adam Kovacs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adam Kovacs filed Critical Adam Kovacs
Publication of NO853241L publication Critical patent/NO853241L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO853241A 1983-12-20 1985-08-16 Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse NO853241L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU834348A HU200093B (en) 1983-12-20 1983-12-20 Process for production of medical compositions against tumour

Publications (1)

Publication Number Publication Date
NO853241L true NO853241L (no) 1985-08-16

Family

ID=10967718

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853241A NO853241L (no) 1983-12-20 1985-08-16 Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse

Country Status (23)

Country Link
US (1) US5068240A (fr)
EP (1) EP0165960B1 (fr)
JP (1) JPS61500729A (fr)
KR (1) KR850700108A (fr)
AU (1) AU574754B2 (fr)
BR (1) BR8407235A (fr)
CA (1) CA1255231A (fr)
DE (1) DE3477881D1 (fr)
DK (1) DK168530B1 (fr)
EG (1) EG17013A (fr)
ES (1) ES8604490A1 (fr)
FI (1) FI853199A0 (fr)
GR (1) GR82477B (fr)
HU (1) HU200093B (fr)
IL (1) IL73825A0 (fr)
IN (1) IN160438B (fr)
IT (1) IT1177485B (fr)
MA (1) MA20305A1 (fr)
NO (1) NO853241L (fr)
NZ (1) NZ210558A (fr)
PT (1) PT79698B (fr)
WO (1) WO1985002769A1 (fr)
ZA (1) ZA849897B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208528B1 (en) 1997-07-15 2007-04-24 Mediquest Therapeutics, Inc. Polyamine analogues as therapeutic and diagnostic agents
US6646149B1 (en) 1997-07-15 2003-11-11 Nicolaas M. J. Vermeulin Polyamine analogues as therapeutic and diagnostic agents
WO1999003823A2 (fr) * 1997-07-15 1999-01-28 Oridigm Corporation Nouveaux analogues de polyamine utilises comme agents therapeutiques et diagnostiques
USRE43327E1 (en) 2001-01-08 2012-04-24 Aminex Therapeutics, Inc. Hydrophobic polyamine analogs and methods for their use
GB0425556D0 (en) * 2004-11-19 2004-12-22 Glaxo Group Ltd Novel compounds
HUP0900271A2 (hu) * 2009-04-30 2010-11-29 Adam Kovacs Levegõszûrõ betét védõmaszkhoz, illetve légkezelõ berendezésekhez széles hatásspektrumú gyógyászati kezelési és prevenciós eljárásokban történõ alkalmazásra
CN103476431B (zh) * 2010-12-30 2015-08-26 株式会社三养生物制药 包含阳离子脂质的用于带负电荷的药物的载体及其制备方法
RU2487122C1 (ru) * 2012-05-24 2013-07-10 Общество с ограниченной ответственностью Научно-производственное объединение "НИИПАВ" Способ получения алкилимидазолина
CA3015849A1 (fr) 2016-03-25 2017-09-28 Mark R. Burns Polyamides biodisponibles
US11865095B2 (en) 2020-09-30 2024-01-09 Aminex Therapeutics, Inc. Combination drug substance of polyamine transport inhibitor and DFMO
CN121443283A (zh) * 2023-04-07 2026-01-30 艾克斯-马赛大学 用作抗菌活性的增强剂的多胺化脂肪酸

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1202M (fr) * 1960-05-09 1962-03-26 American Cyanamid Co Compositions d'amides.
US3085940A (en) * 1960-05-09 1963-04-16 American Cyanamid Co Nu, nu'-methylene-bis-amides for the suppression of tumors

Also Published As

Publication number Publication date
US5068240A (en) 1991-11-26
EP0165960A1 (fr) 1986-01-02
IT1177485B (it) 1987-08-26
GR82477B (en) 1985-04-11
IT8424159A0 (it) 1984-12-20
MA20305A1 (fr) 1985-07-01
EP0165960B1 (fr) 1989-04-26
CA1255231A (fr) 1989-06-06
DK329985D0 (da) 1985-07-19
AU3780185A (en) 1985-07-12
IL73825A0 (en) 1985-03-31
IN160438B (fr) 1987-07-11
DE3477881D1 (en) 1989-06-01
PT79698A (en) 1985-01-01
EG17013A (en) 1993-07-30
KR850700108A (ko) 1985-10-25
WO1985002769A1 (fr) 1985-07-04
BR8407235A (pt) 1985-11-26
FI853199L (fi) 1985-08-20
PT79698B (en) 1987-01-15
HU200093B (en) 1990-04-28
NZ210558A (en) 1988-04-29
ZA849897B (en) 1985-08-28
JPS61500729A (ja) 1986-04-17
DK168530B1 (da) 1994-04-18
FI853199A7 (fi) 1985-08-20
FI853199A0 (fi) 1985-08-20
HUT39602A (en) 1986-10-29
ES8604490A1 (es) 1986-02-01
DK329985A (da) 1985-07-19
ES538852A0 (es) 1986-02-01
AU574754B2 (en) 1988-07-14

Similar Documents

Publication Publication Date Title
EP0196415B1 (fr) Trichostatines A et C comme agents anti-tumeurs
NO853241L (no) Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse
Awad et al. Comparative toxicology of trypan blue, brilliant blue G, and their combination together with polyethylene glycol on human pigment epithelial cells
Patrick Reynolds et al. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant
Richardson et al. Action of polylysine on some ascites tumors in mice.
US20080076772A1 (en) Anti-Inflammatory Agents
CN106924735A (zh) 多巴胺1类受体激动剂在制备肿瘤治疗药物中的用途
Tobey et al. Effects of Bouvardin (NSC 259968), a cyclic hexapeptide from Bouvardia ternifolia, on the progression capacity of cultured Chinese hamster cells
Valadares et al. The effect of a titanocene dichloride derivative, Ti IV (C5H5) 2 NCS2, on the haematopoietic response of Ehrlich tumour-bearing mice
DiPaolo et al. In Vitro Test Systems for Cancer Chemotherapy: I. Inhibition of Dehydrogenases and Growth in the Ehrlich Ascites Tumor
Okamoto et al. Elimination of leukemic cells by the combined use of ether lipids in vitro
Chu et al. Differential characteristics of two newly established human breast carcinoma cell lines
EP0179127B1 (fr) Leucoreguline, une lymphokine antitumorale, et ses utilisations therapeutiques
Bremerskov et al. DNA synthesis during the life cycle of L cells: Morphological, histochemical and biochemical investigations with arabinosylcytosine and thioarabinosylcytosine
Heidelberger et al. Studies on OPSPA: I. The Effect of Several Phosphoramides on Transplanted Tumors
Ozols et al. Direct cloning of human ovarian cancer in soft agar: clinical limitations and pharmacologic applications
Sheridan et al. CSF production and release following endotoxin
Wierda et al. Partial characterization of bone marrow hemopoiesis in mice after cisplatin administration
JPH06501024A (ja) 皮膚腫瘍形成を予防し、存在する腫瘍の後退の原因になるための医薬組成物と方法
Burns et al. Inhibition of marrow granulocytic colony formation by phytohemagglutinin
Blumenfeld et al. A chemotactic inhibitor produced by blast cells and present in the serum of a patient with acute lymphoblastic leukemia
Hug et al. Chemosensitivities of human clonogenic breast tumor cells
Joshi et al. Modified Combination Chemotherapy of Leukemia: An Attempt to Overcome Drug Resistance
Fardon et al. The effect of a yeast extract (PCO) on the mitotic activity of neoplastic and normal cells in vitro
Chaplinski et al. Study of differentiation of fresh myeloid leukemic cells by physiologic agents that induce a human promyelocytic leukemic line (HL-60) to differentiate